Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Parexel
Explore 47 clinical trials worldwide
Search
Showing 1-47 of 47 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Parexel
Clinical Trials (47)
NCT07218523
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
PHASE3
Not yet recruiting
212 participants
Started: Dec 8, 2025 · Completed: Jan 6, 2027
1 condition
2 sponsors
0 locations
NCT07073950
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD)
PHASE4
Not yet recruiting
56 participants
Started: Nov 14, 2025 · Completed: Mar 31, 2027
2 conditions
2 sponsors
0 locations
NCT07216131
A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years
PHASE1
Not yet recruiting
14 participants
Started: Nov 10, 2025 · Completed: Dec 29, 2025
1 condition
2 sponsors
0 locations
NCT07161414
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
PHASE1
Not yet recruiting
40 participants
Started: Oct 21, 2025 · Completed: Mar 28, 2028
1 condition
2 sponsors
0 locations
NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
PHASE1/PHASE2
Recruiting
177 participants
Started: Oct 1, 2025 · Completed: Jan 18, 2029
1 condition
2 sponsors
51 locations
NCT07060365
A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer
PHASE1/PHASE2
Recruiting
30 participants
Started: Sep 2, 2025 · Completed: May 29, 2029
1 condition
2 sponsors
23 locations
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
PHASE3
Recruiting
700 participants
Started: Aug 6, 2025 · Completed: May 22, 2036
1 condition
2 sponsors
195 locations
NCT07088913
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants
PHASE1
Recruiting
18 participants
Started: Jul 28, 2025 · Completed: Sep 29, 2025
1 condition
2 sponsors
1 location
NCT07069712
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
PHASE2
Recruiting
100 participants
Started: Jul 17, 2025 · Completed: Sep 6, 2028
1 condition
2 sponsors
64 locations
NCT07064122
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
PHASE1/PHASE2
Not yet recruiting
72 participants
Started: Jul 4, 2025 · Completed: Oct 5, 2028
1 condition
2 sponsors
17 locations
NCT06951880
A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers
PHASE1
Not yet recruiting
178 participants
Started: Jun 27, 2025 · Completed: Sep 24, 2026
1 condition
2 sponsors
1 location
NCT07024823
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
PHASE1
Recruiting
164 participants
Started: Jun 9, 2025 · Completed: Apr 30, 2026
1 condition
2 sponsors
5 locations
NCT06995820
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
PHASE1
Recruiting
136 participants
Started: Jun 6, 2025 · Completed: Oct 12, 2026
1 condition
2 sponsors
1 location
NCT06942936
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
PHASE1
Recruiting
50 participants
Started: May 28, 2025 · Completed: Feb 6, 2026
1 condition
2 sponsors
2 locations
NCT06929260
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
PHASE1
Recruiting
20 participants
Started: May 21, 2025 · Completed: Mar 2, 2026
1 condition
2 sponsors
4 locations
NCT06926842
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
PHASE2
Recruiting
216 participants
Started: Apr 22, 2025 · Completed: Jun 4, 2026
3 conditions
2 sponsors
25 locations
NCT06908577
An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab
PHASE1
Active, not recruiting
252 participants
Started: Apr 7, 2025 · Completed: Nov 25, 2025
1 condition
2 sponsors
4 locations
NCT06899061
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
PHASE1
Recruiting
45 participants
Started: Mar 25, 2025 · Completed: Nov 19, 2026
1 condition
2 sponsors
4 locations
NCT06792695
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
PHASE2
Recruiting
120 participants
Started: Mar 12, 2025 · Completed: Jun 7, 2028
1 condition
2 sponsors
76 locations
NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1
Recruiting
134 participants
Started: Mar 10, 2025 · Completed: Apr 16, 2029
1 condition
2 sponsors
11 locations
NCT06749457
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
PHASE1/PHASE2
Recruiting
231 participants
Started: Dec 30, 2024 · Completed: Jul 6, 2027
1 condition
2 sponsors
40 locations
NCT06662539
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
PHASE2
Active, not recruiting
494 participants
Started: Dec 9, 2024 · Completed: Mar 16, 2026
1 condition
2 sponsors
32 locations
NCT06315738
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis
PHASE1/PHASE2
Recruiting
36 participants
Started: Aug 19, 2024 · Completed: Nov 30, 2029
1 condition
2 sponsors
7 locations
NCT06015737
A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
PHASE3
Recruiting
460 participants
Started: Jun 29, 2024 · Completed: Dec 29, 2027
1 condition
2 sponsors
273 locations
NCT06307665
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
PHASE3
Recruiting
440 participants
Started: May 20, 2024 · Completed: Oct 13, 2027
1 condition
2 sponsors
124 locations
NCT06189638
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
PHASE2
Active, not recruiting
90 participants
Started: Jan 30, 2024 · Completed: Dec 30, 2027
1 condition
2 sponsors
3 locations
NCT06238466
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
PHASE1
Active, not recruiting
96 participants
Started: Jan 16, 2024 · Completed: Dec 2, 2025
1 condition
2 sponsors
5 locations
NCT06132841
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
PHASE1
Active, not recruiting
52 participants
Started: Nov 13, 2023 · Completed: Mar 23, 2026
1 condition
2 sponsors
3 locations
NCT06103877
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers
PHASE1
Active, not recruiting
140 participants
Started: Nov 1, 2023 · Completed: Jan 13, 2026
1 condition
2 sponsors
3 locations
NCT05943106
BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants
PHASE3
Active, not recruiting
100 participants
Started: Aug 11, 2023 · Completed: May 30, 2027
1 condition
2 sponsors
19 locations
NCT05801029
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
PHASE2
Active, not recruiting
60 participants
Started: Jul 18, 2023 · Completed: Oct 1, 2027
1 condition
2 sponsors
29 locations
NCT05629234
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T)
PHASE3
Active, not recruiting
37 participants
Started: May 8, 2023 · Completed: Feb 22, 2027
1 condition
2 sponsors
27 locations
NCT05701527
A Study of EBC-129 in Advanced Solid Tumours
PHASE1
Recruiting
95 participants
Started: Apr 28, 2023 · Completed: Dec 24, 2026
1 condition
2 sponsors
5 locations
NCT05692180
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
PHASE3
Recruiting
200 participants
Started: Apr 5, 2023 · Completed: May 16, 2032
1 condition
2 sponsors
87 locations
NCT05637112
A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice
N/A
Active, not recruiting
551 participants
Started: Feb 27, 2023 · Completed: Dec 30, 2030
1 condition
2 sponsors
79 locations
NCT05519293
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
PHASE1/PHASE2
Recruiting
76 participants
Started: Dec 15, 2022 · Completed: Feb 28, 2025
1 condition
2 sponsors
4 locations
NCT05450692
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
PHASE3
Active, not recruiting
594 participants
Started: Sep 15, 2022 · Completed: Oct 6, 2025
1 condition
2 sponsors
193 locations
NCT05440643
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
PHASE1/PHASE2
Active, not recruiting
192 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
40 locations
NCT05670782
A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease
PHASE2
Active, not recruiting
314 participants
Started: Jul 19, 2022 · Completed: Nov 13, 2025
1 condition
2 sponsors
3 locations
NCT05488340
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
PHASE2
Recruiting
318 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
20 locations
NCT05061550
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
PHASE2
Recruiting
630 participants
Started: Apr 14, 2022 · Completed: May 9, 2030
1 condition
2 sponsors
98 locations
NCT04765059
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
PHASE3
Active, not recruiting
98 participants
Started: Sep 12, 2021 · Completed: Jun 2, 2026
1 condition
2 sponsors
40 locations
NCT04987203
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
PHASE3
Active, not recruiting
343 participants
Started: Sep 9, 2021 · Completed: Dec 30, 2025
1 condition
3 sponsors
139 locations
NCT04924569
Continence Care Registry
N/A
Active, not recruiting
600 participants
Started: May 24, 2021 · Completed: May 31, 2026
2 conditions
3 sponsors
1 location
NCT04452955
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients with Solid Tumors
PHASE2
Active, not recruiting
51 participants
Started: Dec 12, 2020 · Completed: Dec 1, 2025
1 condition
2 sponsors
5 locations
NCT04008706
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
PHASE3
Active, not recruiting
552 participants
Started: Sep 17, 2019 · Completed: Oct 31, 2025
1 condition
2 sponsors
108 locations
NCT02296125
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
PHASE3
Active, not recruiting
674 participants
Started: Dec 3, 2014 · Completed: Dec 31, 2025
1 condition
2 sponsors
170 locations